(META) Meta Platforms - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US30303M1027
Stock: Social Media, Messaging, Virtual Reality, Wearables
Total Rating 56
Risk 94
Buy Signal 0.19
| Risk 5d forecast | |
|---|---|
| Volatility | 33.0% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -21.80 |
| Character TTM | |
|---|---|
| Beta | 1.291 |
| Beta Downside | 1.109 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.15% |
| CAGR/Max DD | 1.58 |
EPS (Earnings per Share)
Revenue
Description: META Meta Platforms March 05, 2026
Meta Platforms, Inc. (META) develops products for global connection and sharing across mobile, PC, VR, and AI glasses. The company operates in the Interactive Media & Services sector, which is characterized by digital content creation and user engagement platforms.
Its Family of Apps (FoA) segment includes Facebook, Instagram, Messenger, Meta AI, Threads, and WhatsApp. These platforms facilitate social interaction, content sharing, and communication, leveraging network effects for user growth.
The Reality Labs (RL) segment focuses on virtual and augmented reality products, including consumer hardware, software, and content like Meta Quest devices and AI glasses. This segment operates in the nascent but expanding VR/AR market, aiming to build immersive digital experiences.
To deepen your understanding of Metas strategic positioning and financial health, further research on ValueRay is recommended.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 60.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -6.99 > 1.0 |
| NWC/Revenue: 33.28% < 20% (prev 40.39%; Δ -7.11% < -1%) |
| CFO/TA 0.32 > 3% & CFO 115.80b > Net Income 60.46b |
| Net Debt (48.02b) to EBITDA (105.96b): 0.45 < 3 |
| Current Ratio: 2.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.57b) vs 12m ago -1.53% < -2% |
| Gross Margin: 82.00% > 18% (prev 0.82%; Δ 8118 % > 0.5%) |
| Asset Turnover: 62.60% > 50% (prev 59.59%; Δ 3.01% > 0%) |
| Interest Coverage Ratio: 61.69 > 6 (EBITDA TTM 105.96b / Interest Expense TTM 1.42b) |
Altman Z'' 4.96
| A: 0.18 (Total Current Assets 108.72b - Total Current Liabilities 41.84b) / Total Assets 366.02b |
| B: 0.33 (Retained Earnings 121.18b / Total Assets 366.02b) |
| C: 0.27 (EBIT TTM 87.35b / Avg Total Assets 321.04b) |
| D: 0.82 (Book Value of Equity 121.45b / Total Liabilities 148.78b) |
| Altman-Z'' Score: 4.96 = AAA |
Beneish M -2.98
| DSRI: 0.95 (Receivables 19.77b/16.99b, Revenue 200.97b/164.50b) |
| GMI: 1.00 (GM 82.00% / 81.66%) |
| AQI: 1.15 (AQ_t 0.17 / AQ_t-1 0.14) |
| SGI: 1.22 (Revenue 200.97b / 164.50b) |
| TATA: -0.15 (NI 60.46b - CFO 115.80b) / TA 366.02b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of META shares?
As of March 07, 2026, the stock is trading at USD 644.86 with a total of 13,000,591 shares traded.
Over the past week, the price has changed by -0.51%, over one month by -2.51%, over three months by -3.21% and over the past year by +3.02%.
Over the past week, the price has changed by -0.51%, over one month by -2.51%, over three months by -3.21% and over the past year by +3.02%.
Is META a buy, sell or hold?
Meta Platforms has received a consensus analysts rating of 4.54.
Therefore, it is recommended to buy META.
- StrongBuy: 47
- Buy: 13
- Hold: 6
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the META price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 863.2 | 33.9% |
| Analysts Target Price | 863.2 | 33.9% |
META Fundamental Data Overview March 06, 2026
P/E Trailing = 28.414
P/E Forward = 21.7391
P/S = 8.4047
P/B = 7.61
P/EG = 1.0602
Revenue TTM = 200.97b USD
EBIT TTM = 87.35b USD
EBITDA TTM = 105.96b USD
Long Term Debt = 58.74b USD (from longTermDebt, last quarter)
Short Term Debt = 2.21b USD (from shortTermDebt, last quarter)
Debt = 83.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 48.02b USD (from netDebt column, last quarter)
Enterprise Value = 1691.36b USD (1689.06b + Debt 83.90b - CCE 81.59b)
Interest Coverage Ratio = 61.69 (Ebit TTM 87.35b / Interest Expense TTM 1.42b)
EV/FCF = 36.68x (Enterprise Value 1691.36b / FCF TTM 46.11b)
FCF Yield = 2.73% (FCF TTM 46.11b / Enterprise Value 1691.36b)
FCF Margin = 22.94% (FCF TTM 46.11b / Revenue TTM 200.97b)
Net Margin = 30.08% (Net Income TTM 60.46b / Revenue TTM 200.97b)
Gross Margin = 82.00% ((Revenue TTM 200.97b - Cost of Revenue TTM 36.17b) / Revenue TTM)
Gross Margin QoQ = 81.79% (prev 82.03%)
Tobins Q-Ratio = 4.62 (Enterprise Value 1691.36b / Total Assets 366.02b)
Interest Expense / Debt = 0.84% (Interest Expense 708.0m / Debt 83.90b)
Taxrate = 10.20% (2.58b / 25.35b)
NOPAT = 78.44b (EBIT 87.35b * (1 - 10.20%))
Current Ratio = 2.60 (Total Current Assets 108.72b / Total Current Liabilities 41.84b)
Debt / Equity = 0.39 (Debt 83.90b / totalStockholderEquity, last quarter 217.24b)
Debt / EBITDA = 0.45 (Net Debt 48.02b / EBITDA 105.96b)
Debt / FCF = 1.04 (Net Debt 48.02b / FCF TTM 46.11b)
Total Stockholder Equity = 197.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.83% (Net Income 60.46b / Total Assets 366.02b)
RoE = 30.56% (Net Income TTM 60.46b / Total Stockholder Equity 197.85b)
RoCE = 34.04% (EBIT 87.35b / Capital Employed (Equity 197.85b + L.T.Debt 58.74b))
RoIC = 33.50% (NOPAT 78.44b / Invested Capital 234.16b)
WACC = 10.20% (E(1689.06b)/V(1772.96b) * Re(10.67%) + D(83.90b)/V(1772.96b) * Rd(0.84%) * (1-Tc(0.10)))
Discount Rate = 10.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.07%
[DCF] Terminal Value 72.50% ; FCFF base≈49.29b ; Y1≈55.43b ; Y5≈74.21b
[DCF] Fair Price = 383.9 (EV 887.62b - Net Debt 48.02b = Equity 839.59b / Shares 2.19b; r=10.20% [WACC]; 5y FCF grow 14.46% → 2.90% )
EPS Correlation: 85.05 | EPS CAGR: 37.10% | SUE: 1.57 | # QB: 10
Revenue Correlation: 96.06 | Revenue CAGR: 22.59% | SUE: 1.75 | # QB: 3
EPS next Quarter (2026-06-30): EPS=7.12 | Chg7d=-0.009 | Chg30d=+0.033 | Revisions Net=-3 | Analysts=36
EPS current Year (2026-12-31): EPS=29.59 | Chg7d=-0.012 | Chg30d=-0.032 | Revisions Net=-1 | Growth EPS=+26.0% | Growth Revenue=+24.9%
EPS next Year (2027-12-31): EPS=34.36 | Chg7d=+0.028 | Chg30d=+0.874 | Revisions Net=+17 | Growth EPS=+16.1% | Growth Revenue=+17.7%
[Analyst] Revisions Ratio: -0.11 (12 Up / 15 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 10.7% - Earnings Yield 3.5%)
[Growth] Growth Spread = +18.2% (Analyst 25.4% - Implied 7.2%)
P/E Forward = 21.7391
P/S = 8.4047
P/B = 7.61
P/EG = 1.0602
Revenue TTM = 200.97b USD
EBIT TTM = 87.35b USD
EBITDA TTM = 105.96b USD
Long Term Debt = 58.74b USD (from longTermDebt, last quarter)
Short Term Debt = 2.21b USD (from shortTermDebt, last quarter)
Debt = 83.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 48.02b USD (from netDebt column, last quarter)
Enterprise Value = 1691.36b USD (1689.06b + Debt 83.90b - CCE 81.59b)
Interest Coverage Ratio = 61.69 (Ebit TTM 87.35b / Interest Expense TTM 1.42b)
EV/FCF = 36.68x (Enterprise Value 1691.36b / FCF TTM 46.11b)
FCF Yield = 2.73% (FCF TTM 46.11b / Enterprise Value 1691.36b)
FCF Margin = 22.94% (FCF TTM 46.11b / Revenue TTM 200.97b)
Net Margin = 30.08% (Net Income TTM 60.46b / Revenue TTM 200.97b)
Gross Margin = 82.00% ((Revenue TTM 200.97b - Cost of Revenue TTM 36.17b) / Revenue TTM)
Gross Margin QoQ = 81.79% (prev 82.03%)
Tobins Q-Ratio = 4.62 (Enterprise Value 1691.36b / Total Assets 366.02b)
Interest Expense / Debt = 0.84% (Interest Expense 708.0m / Debt 83.90b)
Taxrate = 10.20% (2.58b / 25.35b)
NOPAT = 78.44b (EBIT 87.35b * (1 - 10.20%))
Current Ratio = 2.60 (Total Current Assets 108.72b / Total Current Liabilities 41.84b)
Debt / Equity = 0.39 (Debt 83.90b / totalStockholderEquity, last quarter 217.24b)
Debt / EBITDA = 0.45 (Net Debt 48.02b / EBITDA 105.96b)
Debt / FCF = 1.04 (Net Debt 48.02b / FCF TTM 46.11b)
Total Stockholder Equity = 197.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.83% (Net Income 60.46b / Total Assets 366.02b)
RoE = 30.56% (Net Income TTM 60.46b / Total Stockholder Equity 197.85b)
RoCE = 34.04% (EBIT 87.35b / Capital Employed (Equity 197.85b + L.T.Debt 58.74b))
RoIC = 33.50% (NOPAT 78.44b / Invested Capital 234.16b)
WACC = 10.20% (E(1689.06b)/V(1772.96b) * Re(10.67%) + D(83.90b)/V(1772.96b) * Rd(0.84%) * (1-Tc(0.10)))
Discount Rate = 10.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.07%
[DCF] Terminal Value 72.50% ; FCFF base≈49.29b ; Y1≈55.43b ; Y5≈74.21b
[DCF] Fair Price = 383.9 (EV 887.62b - Net Debt 48.02b = Equity 839.59b / Shares 2.19b; r=10.20% [WACC]; 5y FCF grow 14.46% → 2.90% )
EPS Correlation: 85.05 | EPS CAGR: 37.10% | SUE: 1.57 | # QB: 10
Revenue Correlation: 96.06 | Revenue CAGR: 22.59% | SUE: 1.75 | # QB: 3
EPS next Quarter (2026-06-30): EPS=7.12 | Chg7d=-0.009 | Chg30d=+0.033 | Revisions Net=-3 | Analysts=36
EPS current Year (2026-12-31): EPS=29.59 | Chg7d=-0.012 | Chg30d=-0.032 | Revisions Net=-1 | Growth EPS=+26.0% | Growth Revenue=+24.9%
EPS next Year (2027-12-31): EPS=34.36 | Chg7d=+0.028 | Chg30d=+0.874 | Revisions Net=+17 | Growth EPS=+16.1% | Growth Revenue=+17.7%
[Analyst] Revisions Ratio: -0.11 (12 Up / 15 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 10.7% - Earnings Yield 3.5%)
[Growth] Growth Spread = +18.2% (Analyst 25.4% - Implied 7.2%)